Found: 19
Select item for more details and to access through your institution.
Interleukin-6 and C-reactive protein levels after 3 years of treatment with darunavir/ritonavir monotherapy or darunavir/ritonavir + two nucleoside reverse transcriptase inhibitors in the MONET trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 7, p. 1804, doi. 10.1093/jac/dks102
- By:
- Publication type:
- Article
96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA <50 copies/mL at baseline.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 8, p. 1878, doi. 10.1093/jac/dkr199
- By:
- Publication type:
- Article
Correction to: Evaluation of Cardiovascular Disease Risk in HIV‑1-Infected Patients Treated with Darunavir.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Evaluation of Cardiovascular Disease Risk in HIV-1-Infected Patients Treated with Darunavir.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 3, p. 199, doi. 10.1007/s40268-018-0238-8
- By:
- Publication type:
- Article
Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials.
- Published in:
- AIDS Research & Treatment, 2014, p. 1, doi. 10.1155/2014/636584
- By:
- Publication type:
- Article
The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19525
- By:
- Publication type:
- Article
Analysis of neurocognitive function and CNS endpoints in the PROTEA trial: darunavir/ritonavir with or without nucleoside analogues.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19526
- By:
- Publication type:
- Article
Budget Impact Analysis of Switching to Darunavir/Ritonavir Monotherapy for HIV-Infected People in Spain.
- Published in:
- Applied Health Economics & Health Policy, 2012, v. 10, n. 2, p. 139, doi. 10.2165/11598380-000000000-00000
- By:
- Publication type:
- Article
No Difference in the Rate of Change in Telomere Length or Telomerase Activity in HIV-Infected Patients after Three Years of Darunavir/Ritonavir with and without Nucleoside Analogues in the MONET Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0109718
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women.
- Published in:
- AIDS Reviews, 2017, v. 19, n. 1, p. 16
- By:
- Publication type:
- Article
Effects of Switching To Protease Inhibitor Monotherapy on Nucleoside Analogue-Related Adverse Events.
- Published in:
- AIDS Reviews, 2014, v. 16, n. 4, p. 236
- By:
- Publication type:
- Article
When can HIV clinical trials detect treatment effects on drug resistance?
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
When can HIV clinical trials detect treatment effects on drug resistance?
- Published in:
- International Journal of STD & AIDS, 2015, v. 26, n. 4, p. 268, doi. 10.1177/0956462414536885
- By:
- Publication type:
- Article
Predictors of long-term HIV RNA suppression on darunavir/ritonavir monotherapy in the MONET trial.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Geographic and Population Distributions of Human Immunodeficiency Virus (HIV)–1 and HIV-2 Circulating Subtypes: A Systematic Literature Review and Meta-analysis (2010–2021).
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 11, p. 1583, doi. 10.1093/infdis/jiad327
- By:
- Publication type:
- Article
Performance of the Abbott RealTime HIV-1 assay versus the Roche Amplicor HIV-1 MonitorTM Test, v1.5, UltraSensitive assay for samples with low plasma HIV-1 RNA copy numbers.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Performance of the Abbott RealTime HIV-1 assay versus the Roche Amplicor HIV-1 MonitorTM Test, v1.5, UltraSensitive assay for samples with low plasma HIV-1 RNA copy numbers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 6, p. 1708, doi. 10.1093/jac/dkt538
- By:
- Publication type:
- Article
The MONET trial: correlation between Hepatitis C coinfection and HIV RNA responses during darunavir/ritonavir monotherapy, for patients with HIV RNA <50 copies/mL at baseline.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV.
- Published in:
- AIDS Research & Therapy, 2018, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12981-018-0204-0
- By:
- Publication type:
- Article